Not exact matches
Profectus BioSciences in Tarrytown, New York, which is developing a similar
vaccine, needs some $ 2 million to produce it under good
manufacturing practice standards, a prerequisite for any
human study.
The Pilot Bioproduction Facility headed by Dr. Kenneth H. Eckels, produced small batches of
vaccine candidates that were used for the preclinical studies and is currently
manufacturing a
vaccine lot for use in initial
human clinical studies.
About $ 420 million of the money would go to the Office of the Assistant Secretary for Preparedness and Response within the Department of Health and
Human Services for developing and
manufacturing vaccines to counter pandemic flu.
Dr. Leo Stamatatos, an immunologist in Fred Hutch's
Vaccine and Infectious Disease Division, has received funding from the National Institutes of Health to begin manufacturing an HIV vaccine candidate designed to stimulate the production of broadly neutralizing antibodies and to test the experimental vaccine in human clinical
Vaccine and Infectious Disease Division, has received funding from the National Institutes of Health to begin
manufacturing an HIV
vaccine candidate designed to stimulate the production of broadly neutralizing antibodies and to test the experimental vaccine in human clinical
vaccine candidate designed to stimulate the production of broadly neutralizing antibodies and to test the experimental
vaccine in human clinical
vaccine in
human clinical trials.
The use of
human embryonic stem cells, as opposed to patient blood, as the starting material for AST - VAC2 provides a scalable system for the production of a large number of
vaccine doses in a single lot, reducing
manufacturing costs, enabling «off - the - shelf» availability, and ensuring product consistency.
Sinovac Biotech, Ltd. is a fully integrated, profitable China - based biopharmaceutical company that focuses on the research, development,
manufacturing and commercialization of
vaccines that protect against
human infectious diseases.
Sinovac Biotech Ltd. is biopharmaceutical company that focuses on research, development,
manufacturing and commercialization of
vaccines that protect against
human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza and mumps, as well as animal rabies
vaccine.
Anne T, the
human vaccine companies have a lot of experience working with flu, and with
manufacturing human flu
vaccines.